EDP Sciences logo
Web of Conferences logo
Search
Menu
All issues Volume 319 (2021) E3S Web Conf., 319 (2021) 01003 References
Open Access
Issue
E3S Web Conf.
Volume 319, 2021
International Congress on Health Vigilance (VIGISAN 2021)
Article Number 01003
Number of page(s) 4
DOI https://doi.org/10.1051/e3sconf/202131901003
Published online 09 November 2021
  1. Eze EC, Chenia HY, El Zowalaty ME. Acinetobacter baumannii biofilms: effects of physicochemical factors, virulence, antibiotic resistance determinants, gene regulation, and future antimicrobial treatments. Infect Drug Resist. ( 2018 ) ;11:2277-2299. [CrossRef] [Google Scholar]
  2. Ballouz, Tala, et al. “Risk Factors, Clinical Presentation, and Outcome of Acinetobacter Baumannii Bacteremia.” Frontiers in Cellular and Infection Microbiology, vol. 7, ( 2017 ) , [CrossRef] [PubMed] [Google Scholar]
  3. Valérie Delbos. Manifestations cliniques et traitement des infections à Acinetobacter baumannii, Revue Francophone des Laboratoires, Volume 2012 , Issue 441, (April 2012), Pages 59–65 [CrossRef] [Google Scholar]
  4. Aguirre-Avalos G, Mijangos-Méndez JC, Amaya-Tapia G. Bacteriemia por Acinetobacter baumannii. Rev Med Inst Mex Seguro Soc. (2010 ) ;48 (6) :625–634. [Google Scholar]
  5. Recommandations du CASFM / EUCAST ( 2015 ) v.1.0. Comité de l’Antibiogramme de la Société Française de Microbiologie (SFM) - European Committee on Antimicrobial Susceptibility Testing (EUCAST). [Google Scholar]
  6. Société Française de Microbiologie . Bactériémies et fongémies – hémocultures. Rémic : Référentiel en microbiologie ( 2015 ) : 137–152 p [Google Scholar]
  7. Kant Khanal, Laxmi. “Bacteriological Profile of Blood Culture and Antibiogram of the Bacterial Isolates in a Tertiary Care Hospital.” International Journal of Health Sciences and Research, vol. 10, no. 8, ( 2020 ) [Google Scholar]
  8. Bandy A, Almaeen AH (2020) Pathogenic spectrum of blood stream infections and resistance pattern in Gram-negative bacteria from Aljouf region of Saudi Arabia. PLoS ONE 15(6): e0233704. [CrossRef] [PubMed] [Google Scholar]
  9. Ali Z. Le .profil bactérilogique des bactériémies et l’état de résistance aux antibiotiques Thèse de Médecine N° 219 ( 2019 ) . Faculté de Médecine et de Pharmacie de Marrakech [Google Scholar]
  10. Ahmed L.Aspects microbiologiques et résistance aux antibiotiques de bactéries isolées d’hémoculture à l’hôpital militaire Moulay Ismail de Meknès de 2015 à 2018 . Thèse de Médecine N° 078 (2020 ) . Faculté de Médecine et de Pharmacie de Fès. [Google Scholar]
  11. Gramatniece, A., et al. “Control of Acinetobacter Baumannii Outbreak in the Neonatal Intensive Care Unit in Latvia: Whole-Genome Sequencing Powered Investigation and Closure of the Ward.” Antimicrobial Resistance & Infection Control, vol. 8, no. 1, ( 2019 ) [CrossRef] [Google Scholar]
  12. Tang, C.q., et al. “Epidemiology and Outcomes of Bloodstream Infections in 177 Severe Burn Patients from an Industrial Disaster: a Multicentre Retrospective Study.” Clinical Microbiology and Infection, vol. 24, no. 2, ( 2018 ). [Google Scholar]
  13. Yang, Shuangshuang, et al. “Determinants of Mortality in Patients with Nosocomial Acinetobacter Baumannii Bacteremia in Southwest China: A Five-Year Case-Control Study.” Canadian Journal of Infectious Diseases and Medical Microbiology, vol. 2018, ( 2018 ) , pp. 1–9. [Google Scholar]
  14. Papathanakos, Georgios, et al. “Colistin-Resistant Acinetobacter Baumannii Bacteremia: A Serious Threat for Critically Ill Patients.” Microorganisms, vol. 8, no. 2, ( 2020 ) , p. 287. [CrossRef] [Google Scholar]
  15. Villar M, Cano ME, Gato E, Garnacho-Montero J, Miguel Cisneros J, Ruíz de Alegría C, et al. Epidemiologic and clinical impact of Acinetobacter baumannii colonization and infection: a reappraisal. Medicine (Baltimore). (2014 );93[5]:202–10. [Google Scholar]
  16. Russo, Alessandro, et al. “Bloodstream Infections Caused by Carbapenem-Resistant Acinetobacter Baumannii: Clinical Features, Therapy and Outcome from a Multicenter Study.” Journal of Infection, vol. 79, no. 2, (2019 ), pp. 130–138., [CrossRef] [Google Scholar]
  17. Maraki, Sofia, et al. “A 5-Year Surveillance Study on Antimicrobial Resistance OfAcinetobacter BaumanniiClinical Isolates from a Tertiary Greek Hospital.” Infection & Chemotherapy, vol. 48, no. 3, ( 2016 ) , p. 190.,. [CrossRef] [PubMed] [Google Scholar]
  18. L, Qiao, et al. “Analysis of Risk Factors on Prognosis of Acinetobacter Baumannii Bloodstream Infection.” Clinical Proteomics and Bioinformatics, vol. 1, no. 2, ( 2016 ) , [CrossRef] [Google Scholar]
  19. World Health Organization . WHO publishes list of bacteria for which new antibiotics are urgently needed . (2017 ) . [Google Scholar]
  20. Protic D, Pejovic A, Andjelkovic D, Djukanovic N, Savic D, Piperac P, et al. Nosocomial infections caused by acinetobacter baumannii: Are we losing the battle? Surg Infect (Larchmt)(2016) ;17(2):236–242. [Google Scholar]
  21. Isler B, Yohei D, Bonomo RA, Paterson D. New Treatment Options against Carbapenem-Resistant Acinetobacter baumannii Infections. Antimicrob Agents Chemother. (2019 );63(1):1–17. [Google Scholar]
  22. Lob, Sibylle H et al. “Regional differences and trends in antimicrobial susceptibility of Acinetobacter baumannii.” International journal of antimicrobial agents vol. 47,4 (2016): 317–323. [CrossRef] [PubMed] [Google Scholar]
  23. Afhami, Shirin, et al. “Antimicrobial Resistance Pattern of Acinetobacter; a Multicenter Study, Comparing European Committee on Antimicrobial Susceptibility Testing (EUCAST) and the Clinical and Laboratory Standards Institute (CLSI); Evaluation of Susceptibility Testing Methods for Polymyxin.” Immunopathologia Persa, vol. 7, no. 1,( 2020 ). [Google Scholar]
  24. Zuniga-Moya JC, Caballero CA, Loucel-Linares M, Benitez MJ, Zambrano-Garcia E, Fajardo LV, et al. Antimicrobial profile of Acinetobacter baumannii at a tertiary hospital in Honduras: a cross-sectional analysis. Rev Panam Salud Publica.(2020) ;44:e46. [PubMed] [Google Scholar]
  25. Shi, Jingyi, et al. “Multidrug Resistant and Extensively Drug Resistant Acinetobacter Baumannii Hospital Infection Associated with High Mortality: a Retrospective Study in the Pediatric Intensive Care Unit.” BMC Infectious Diseases, vol. 20, no. 1, ( 2020 ) , [PubMed] [Google Scholar]
  26. Konca C, Tekin M, Geyik M. Susceptibility Patterns of Multidrug-Resistant Acinetobacter baumannii. Indian J Pediatr. 2021 Feb;88(2):120–126 [CrossRef] [PubMed] [Google Scholar]
  27. Jaidane, Nadia & Mansour, Wejdene & Bonnin, Rémy & Ghardallou, Mariem & Chaouch, Cherifa & Rachida, Golli & Nesrine, Kalboussi & Noureddine, Boujaafar & Olfa, Bouallegue & Naas, Thierry. (2019). Temporal Variation in Antibiotic Resistance of Acinetobacter baumannii in a Teaching Hospital in Tunisia: Correlation with Antimicrobial Consumption. The Open Microbiology Journal. 13. 106–111. [CrossRef] [Google Scholar]
  28. El Kettani, Assiya et al. “Prevalence of Acinetobacter baumannii bacteremia in intensive care units of Ibn Rochd University Hospital, Casablanca.” Iranian journal of microbiology vol. 9 (6) (2017): 318-323. [PubMed] [Google Scholar]
  29. Yun Cai, Dong Chai, Rui Wang, Beibei Liang, Nan Bai, Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies, Journal of Antimicrobial Chemotherapy, Volume 67, Issue 7, ( July 2012 ) , Pages 1607–1615, [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.